Laboratory-Developed Test for SARS-CoV-2 Using Saliva Samples at the University of California, Riverside
Hai, R.; Collin, M.; Tsau, S.; Raygoza, D.; Morrison, J.; Carrillo, A. J.; Collier, L. A.; Bayubay, W.; Han, K.; Kaloshian, I.; Borkovich, K. A.
Show abstract
Here we describe a relatively quick, simple, economical and accurate laboratory developed test (LDT) for detection of SARS-CoV-2 in heated and diluted saliva samples without RNA extraction. Our protocol is a variation of the University of Illinois Urbana-Champaign SHIELD LDT. Differences include chilling of the samples during dilution and using a reduced volume for the qRT-PCR reactions. The level of detection for our LDT is 3125 copies/ml, which compares favorably with other saliva-based tests. Initial validation studies with a limited number of patient samples have demonstrated excellent agreement between results using our LDT and those obtained from external laboratories. The cost of consumables for our test is under $8 and a throughput of 1000 tests/day can be achieved with 3-4 personnel.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Development and Implementation of a Simple and Rapid Extraction-Free Saliva SARS-CoV-2 RT-LAMP Workflow for Workplace Surveillance 97%
- Rapid processing of SARS-CoV-2 containing specimens for direct RT-PCR 97%
- Development and validation of a highly sensitive and specific electrochemical assay to quantify anti-SARS-CoV-2 IgG antibodies to facilitate pandemic surveillance and monitoring of vaccine response 96%
Similar papers in this journal
- Saliva Is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2 96%
- Optimal processing of tongue swab samples for Mycobacterium tuberculosis detection by the Xpert MTB/RIF Ultra assay 95%
- Real-time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with Variants of Concern 95%
Similar papers in this journal
- Evaluation of sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing 96%
- Validation of a Single-step, Single-tube Reverse Transcription-Loop-Mediated Isothermal Amplification Assay for Rapid Detection of SARS-CoV-2 RNA 95%
- Acceptable Performance of the Abbott ID NOW Among Symptomatic Individuals with Confirmed COVID-19 94%
Similar papers in this journal
- Verification of the Abbott Alinity m Resp-4-Plex Assay for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus 95%
- User acceptability of saliva and gargle samples for identifying COVID-19 positive high-risk workers 95%
- Analytical Performance of the AMDI Fast PCR Mini Respiratory Panel 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.